Loading organizations...
Key people at Criteria Bio Ventures.
Criteria Bio Ventures functions as a specialized life sciences venture fund, backing private biotech companies across Europe and North America, with a specific focus on Spain and Portugal. The firm invests in disruptive innovations addressing significant unmet medical needs, supporting diverse modalities and disease areas. It provides sustained assistance to portfolio companies, aiming for meaningful impact in healthcare.
This venture fund was established as a dedicated life sciences vehicle by Caixa Capital Risc, the venture arm of CriteriaCaixa, which manages "la Caixa" Foundation's wealth. Leveraging Caixa Capital Risc's extensive experience, the fund's formation reflected an insight into specialized biotech support, building on its parent foundation's long-standing commitment to healthcare advancement.
Criteria Bio Ventures partners with entrepreneurs and innovative biotech firms transforming patient outcomes. The fund envisions shaping healthcare's future by fostering transformative solutions and guiding portfolio companies towards significant impact. Its mission is to develop pioneering technologies that advance patient care and contribute to global health evolution.
Key people at Criteria Bio Ventures.
Criteria Bio Ventures has 1 tracked investment across 1 company. The latest tracked deal is $68.0M Series B in NRG Therapeutics in September 2025.
| Date | Company | Round | Lead Investor(s) | Co-Investor(s) |
|---|---|---|---|---|
| Sep 1, 2025 | NRG Therapeutics | $68.0M Series B | Laurence Barker | Daniela Couto, Brandon Capital Partners, Novartis Venture Fund, SV Health Investors, Brandon Capital, Emma Johnson, Charlotte Kremers, Florian Müllershausen, Francesco Draetta |